Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
CV2-75
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
6D60
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
BG10-19
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
REGN3051
SARS-CoV-2(2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2M11
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
47D11
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
CT P63
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
CT P66
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
9MW 3311
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
NBE-002